Evidence map›Paper›PMID 41476586›Full record

ArticleFrontiers in oncology2025

Early prediction of tumor response to carbon ion radiotherapy via

Caiyue Ren, Jian Chen, Jingfang Mao, Jiangang Zhang, Zili Li, Kailiang Wu, Jingyi Cheng

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Caiyue RenDepartment of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.
Jian ChenShanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Jingfang MaoShanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Jiangang ZhangShanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Zili LiShanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Kailiang WuShanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Jingyi ChengDepartment of Nuclear Medicine, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypoxia increases resistance to carbon ion radiotherapy (CIRT) in locally advanced non-small-cell lung cancer (LA-NSCLC, stage II-III). This study aimed to develop a hypoxia-related model based on Methods: A total of 42 LA-NSCLC patients, including 25 (60%) with squamous cell carcinoma (SCC) and 17 (40%) with non-SCC, underwent Results: Among the 42 patients analyzed, 17 (40%) achieved partial response (PR) while 25 (60%) had stable disease (SD). Conclusion:

Indexed as

18F-FMISO PET/CTcarbon ion radiotherapylocally advanced non-small-cell lung cancerresponse predictiontumor hypoxia

Identifiers

PMID41476586
PMCPMC12747971

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.